XOMA Royalty (XOMA) Cash & Current Investments (2010 - 2026)

XOMA Royalty (XOMA) reported Cash & Current Investments of $86.1 million for Q1 2026, down 7.07% on a YoY basis from $92.6 million in Q1 2025, and up 3.34% sequentially from $83.3 million in Q4 2025.

XOMA Royalty (XOMA) Cash & Current Investments (2010 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 17 years of Cash & Current Investments data on file, last reported at $86.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments fell 7.07% year-over-year to $86.1 million; the trailing twelve-month figure through Mar 2026 stood at $86.1 million (down 7.07% YoY), and the FY2025 full-year result was $83.3 million, down 19.11% from the prior year.
  • Cash & Current Investments rose to $86.1 million in Q1 2026, from $83.3 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $153.4 million in Q4 2023 to a low of $335000.0 in Q4 2022.
  • A 5-year average of $75.3 million and a median of $83.7 million in 2022 frame the typical range for Cash & Current Investments.
  • Across the five-year window, Cash & Current Investments slumped 99.65% in 2022 and soared 45705.97% in 2023, its largest moves.
  • Tracing XOMA's Cash & Current Investments over 5 years: stood at $335000.0 in 2022, then soared by 45705.97% to $153.4 million in 2023, then tumbled by 32.89% to $103.0 million in 2024, then decreased by 19.11% to $83.3 million in 2025, then rose by 3.34% to $86.1 million in 2026.
  • Business Quant data shows XOMA's Cash & Current Investments at $86.1 million in Q1 2026, $83.3 million in Q4 2025, and $108.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 283.54 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 61.40 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 5.18 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 XOMA Royalty 478.42 Mn 412.34 Mn - 86.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 86.09 Mn
Dec 31, 2025 83.31 Mn
Sep 17, 2025 108.00 Mn
Jun 30, 2025 7.07 Mn
Mar 31, 2025 92.65 Mn
Dec 31, 2024 102.98 Mn
Sep 30, 2024 4.80 Mn
Jun 30, 2024 144.60 Mn
Mar 31, 2024 136.40 Mn
Dec 31, 2023 153.45 Mn
Sep 30, 2023 33.69 Mn
Jun 30, 2023 31.77 Mn
Mar 31, 2023 44.61 Mn
Dec 31, 2022 335,000.00
Sep 30, 2022 78.73 Mn
Jun 30, 2022 83.71 Mn
Mar 31, 2022 88.34 Mn
Dec 31, 2021 95.38 Mn
Sep 30, 2021 72.17 Mn
Jun 30, 2021 81.26 Mn